Loncastuximab Tesirine and Rituximab Followed by DA-EPOCH-R for Treating Patients With High-Risk Diffuse Large B-cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Relmacabtagene Autoleucel as First-Line Therapy for High-Risk Large B-Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Autologous T Cells Targeting HPV16 HPV18 & Survivin in Patients With R/R HPV-related Oropharyngeal Cancers
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy
- Status
- RECRUITING
- Phase
- PHASE2
Pediatric Study of GVHD Ppx w/o Calcineurin Inhibitors After Day60 Post First Allo HSCT for Hematological Malignancies.
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Evaluate Change in Disease Activity of Subcutaneous (SC) Epcoritamab Combined With Intravenous and Oral Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone (R-CHOP) or R-CHOP in Adult Participants With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Anti-BCMA Chimeric Antigen Receptor T Cells for Relapsed or Refractory Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Safety and Efficacy of ThisCART19A Bridging Hematopoietic Stem Cell Transplantation in Patients With Refractory or Relapsed B-cell Acute Lymphoblastic Leukemia
- Status
- UNKNOWN
- Phase
- PHASE1
CISH Inactivated TILs in the Treatment of NSCLC
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
CD34+ Transplants for Leukemia and Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Allogenic CD19-targeting CAR-γδT Cell Therapy in R/R NHL
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of Brexucabtagene Autoleucel in Adults With Rare B-cell Malignancies
- Status
- TERMINATED
- Phase
- PHASE2
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
- Status
- RECRUITING
- Phase
- PHASE2
Exploratory Study of Novel MSLN CAR-T Cell Therapy in Patients With MSLN-positive Advanced Refractory Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE1
Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)
- Status
- RECRUITING
- Phase
- PHASE1
High-dose Chemotherapy+G-CSF in Peripheral Blood Stem Cell Mobilization in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- NA
Novel CAR-T Cell Therapy in the Treatment of Hematopoietic and Lymphoid Malignancies
- Status
- WITHDRAWN
- Phase
- PHASE1
Investigate the Contribution of Ipatasertib to Neoadjuvant Chemotherapy Plus Atezolizumab in TNBC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2